A systematic review on the effect of bevacizumab in exudative age-related macular degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A systematic review on the effect of bevacizumab in exudative age-related macular degeneration

Published:2008-10-09 Issue:1 Volume:247 Page:1-11
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Schouten Jan S. A. G.,La Heij Ellen C.,Webers Carroll A. B.,Lundqvist Igor J.,Hendrikse Fred

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/content/pdf/10.1007/s00417-008-0952-y

Reference48 articles.

1. Abraham Marin ML, Cortes Luna CF, Alvarez Rivera G, Hernandez Rojas M, Quiroz Mercado H, Morales Canton V (2006) Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study. Graefes Arch Clin Exp Ophthalmol 245:651–655, doi: 10.1007/s00417-006-0411-6

2. Aggio FB, Farah ME, Silva WC, Melo GB (2006) Intravitreal bevacizumab for exudative age-related macular degeneration after multiple treatments. Graefes Arch Clin Exp Ophthalmol 245:215–220, doi: 10.1007/s00417-006-0412-5

3. Aisenbrey S, Ziemssen F, Volker M, Gelisken F, Szurman P, Jaissle G et al (2006) Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 245:941–948, doi: 10.1007/s00417-006-0471-7

4. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ (2006) Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 113:363–372, doi: 10.1016/j.ophtha.2005.11.019

5. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Ezzat MK, Singh RJ (2007) Pharmacokinetics of intravitreal ranibizumab (Lucentis). Ophthalmology 114:2179–2182, doi: 10.1016/j.ophtha.2007.09.012

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems;International Journal of Pharmaceutics;2024-06

2. Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization;Photodiagnosis and Photodynamic Therapy;2024-04

3. Microneedles for various ocular diseases;Design and Applications of Microneedles in Drug Delivery and Therapeutics;2024

4. Long-term choroidal thickness changes based on the subtype of macular neovascularization in neovascular age-related macular degeneration (5-year follow-up);Graefe's Archive for Clinical and Experimental Ophthalmology;2023-10-21

5. Anti-angiogenic carbon nanovesicles loaded with bevacizumab for the treatment of age-related macular degeneration;Carbon;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3